Home » Topics » BioWorld Science

BioWorld Science
RSS

FUJIFILM, Nagoya City University patent flycosylated chlorin e6 derivatives

June 29, 2018

New MAP4K1 inhibitors identified at Ariad Pharmaceuticals

June 29, 2018

EMA committee recommends approval of Cablivi for aTTP

June 29, 2018

Phase III MEDALIST study of luspatercept meets primary and key secondary endpoints

June 29, 2018

ProQR initiates phase I/II WINGS trial of QR-313

June 29, 2018

Trevena completes first-in-human study of TRV-250 for treatment of acute migraine

June 29, 2018

Ziopharm initiates phase I trial of Ad-RTS-hIL-12 plus veledimex with nivolumab in recurrent GBM

June 29, 2018

INDIGO-1 study of gemcabene in severe hypertriglyceridemia meets primary endpoint

June 29, 2018

Arsanis discontinues phase II study of ASN-100

June 29, 2018

European Commission approves Xeljanz for active psoriatic arthritis

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...